These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 7643999)
1. Delayed tissue-plasminogen activator therapy in a rabbit model of thromboembolic stroke. Gross CE; Raymond SJ; Howard DB; Bednar MM Neurosurgery; 1995 Jun; 36(6):1172-7. PubMed ID: 7643999 [TBL] [Abstract][Full Text] [Related]
2. Diffusion-, T2-, and perfusion-weighted nuclear magnetic resonance imaging of middle cerebral artery embolic stroke and recombinant tissue plasminogen activator intervention in the rat. Jiang Q; Zhang RL; Zhang ZG; Ewing JR; Divine GW; Chopp M J Cereb Blood Flow Metab; 1998 Jul; 18(7):758-67. PubMed ID: 9663506 [TBL] [Abstract][Full Text] [Related]
3. The effect of oral antiplatelet agents on tissue plasminogen activator-mediated thrombolysis in a rabbit model of thromboembolic stroke. Bednar MM; Quilley J; Russell SR; Fuller SP; Booth C; Howard D; Gross CE Neurosurgery; 1996 Aug; 39(2):352-9. PubMed ID: 8832673 [TBL] [Abstract][Full Text] [Related]
4. Combination tissue plasminogen activator and ticlopidine therapy in a rabbit model of acute thromboembolic stroke. Bednar MM; Raymond-Russell SJ; Booth CL; Gross CE Neurol Res; 1996 Feb; 18(1):45-8. PubMed ID: 8714536 [TBL] [Abstract][Full Text] [Related]
5. Neuroprotection with NBQX and thrombolysis with rt-PA in rat embolic stroke. Overgaard K; Sereghy T; Pedersen H; Boysen G Neurol Res; 1993 Oct; 15(5):344-9. PubMed ID: 7905610 [TBL] [Abstract][Full Text] [Related]
6. Tissue plasminogen activator reduces brain injury in a rabbit model of thromboembolic stroke. Bednar MM; McAuliffe T; Raymond S; Gross CE Stroke; 1990 Dec; 21(12):1705-9. PubMed ID: 2124736 [TBL] [Abstract][Full Text] [Related]
7. Neuroprotection by excitatory amino acid antagonist augments the benefit of thrombolysis in embolic stroke in rats. Sereghy T; Overgaard K; Boysen G Stroke; 1993 Nov; 24(11):1702-8. PubMed ID: 8236347 [TBL] [Abstract][Full Text] [Related]
8. Delayed adjuvant therapy with the 21-aminosteroid U74006F and the anion channel blocker L644-711 does not improve outcome following thrombolytic therapy in a rabbit model of thromboembolic stroke. Gross CE; Kimelberg HK; Raymond-Russell S; Booth C; Bednar MM Surg Neurol; 1997 Jan; 47(1):60-5; discussion 66-7. PubMed ID: 8986168 [TBL] [Abstract][Full Text] [Related]
9. Effect of intra-arterial tissue plasminogen activator and urokinase on autologous arterial emboli in the cerebral circulation of rabbits [corrected]. Benes V; Zabramski JM; Boston M; Puca A; Spetzler RF Stroke; 1990 Nov; 21(11):1594-9. PubMed ID: 2122553 [TBL] [Abstract][Full Text] [Related]
10. The effect of the 21-aminosteroid U74006F in a rabbit model of thromboembolic stroke. Wilson JT; Bednar MM; McAuliffe TL; Raymond S; Gross CE Neurosurgery; 1992 Nov; 31(5):929-33; discussion 933-4. PubMed ID: 1436419 [TBL] [Abstract][Full Text] [Related]
11. Complement depletion does not reduce brain injury in a rabbit model of thromboembolic stroke. Lew SM; Gross CE; Bednar MM; Russell SJ; Fuller SP; Ellenberger CL; Howard D Brain Res Bull; 1999 Feb; 48(3):325-31. PubMed ID: 10229342 [TBL] [Abstract][Full Text] [Related]
12. Tissue-type plasminogen activator improves neurological functions in a rat model of thromboembolic stroke. Sakurama T; Kitamura R; Kaneko M Stroke; 1994 Feb; 25(2):451-6. PubMed ID: 8303756 [TBL] [Abstract][Full Text] [Related]
13. Early (1 h) administration of tissue plasminogen activator reduces infarct volume without increasing hemorrhagic transformation after focal cerebral embolization in rats. Zhang RL; Chopp M; Zhang ZG; Divine G J Neurol Sci; 1998 Sep; 160(1):1-8. PubMed ID: 9804110 [TBL] [Abstract][Full Text] [Related]
14. A comparison of intra-arterial and intravenous tissue-type plasminogen activator on autologous arterial emboli in the cerebral circulation of rabbits. Hamilton MG; Lee JS; Cummings PJ; Zabramski JM Stroke; 1994 Mar; 25(3):651-5; discussion 656. PubMed ID: 8128521 [TBL] [Abstract][Full Text] [Related]
15. [Does the result of thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in rabbits depend on the erythrocyte- and fibrin-content of a thrombus?]. Kirchhof K; Sikinger M; Welzel T; Zoubaa S; Sartor K Rofo; 2004 Jan; 176(1):98-105. PubMed ID: 14712413 [TBL] [Abstract][Full Text] [Related]
16. Optimized thrombolysis of cerebral clots with tissue-type plasminogen activator in a rabbit model of embolic stroke. Thomas GR; Thibodeaux H; Bennett WF; Refino CJ; Badillo JM; Errett CJ; Zivin JA J Pharmacol Exp Ther; 1993 Jan; 264(1):67-73. PubMed ID: 8423552 [TBL] [Abstract][Full Text] [Related]
17. Increased therapeutic efficacy with rt-PA and anti-CD18 antibody treatment of stroke in the rat. Zhang RL; Zhang ZG; Chopp M Neurology; 1999 Jan; 52(2):273-9. PubMed ID: 9932943 [TBL] [Abstract][Full Text] [Related]
18. Activation of complement by tissue plasminogen activator, but not acute cerebral ischemia, in a rabbit model of thromboembolic stroke. Bednar MM; Gross CE; Russell SR; Short D; Giclas PC J Neurosurg; 1997 Jan; 86(1):139-42. PubMed ID: 8988092 [TBL] [Abstract][Full Text] [Related]
19. The safety and angiographic efficacy of tissue plasminogen activator in a cerebral embolization model. Phillips DA; Fisher M; Smith TW; Davis MA Ann Neurol; 1988 Apr; 23(4):391-4. PubMed ID: 3132892 [TBL] [Abstract][Full Text] [Related]